Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trial

ABSTRACT:

SUBMITTER: Zhang W 

PROVIDER: S-EPMC12859413 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature